Patents by Inventor Johannes Maarten Van Den Brink

Johannes Maarten Van Den Brink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11555182
    Abstract: Variants of chymosin with improved milk clotting properties.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: January 17, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Christian Jaeckel, Martin Lund, Johannes Maarten Van Den Brink
  • Patent number: 11525129
    Abstract: Disclosed are peptides and dimeric peptides exhibiting beta-galactosidase enzyme activity, as well as methods for producing a dairy product using them, and dairy products made by such methods. In some embodiments, the peptides exhibit beta-galactosidase enzyme activity at low and/or high temperatures.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: December 13, 2022
    Assignee: Chr. Hansen A/S
    Inventors: Hans Raj, Pernille Smith, Thomas Eckhardt, Vojislav Vojinovic, Charlotte Elisabeth Grüner Schöller, Johannes Maarten Van Den Brink
  • Publication number: 20220304323
    Abstract: The present invention relates to new improved methods for expressing native lactases in their native hosts. Methods for homologous as well as heterologous expression of lactase in lactic acid bacteria with altered expression dynamics are comprised by present invention.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 29, 2022
    Applicant: Chr. Hansen A/S
    Inventors: Hans RAJ, Charlotte Elisabeth Grüner SCHÖLLER, Kim Ib SOERENSEN, Johannes Maarten VAN DEN BRINK, Ahmad ZEIDAN, Martin Holm RAU, Paula GASPAR, George Nabin BAROI
  • Publication number: 20220232880
    Abstract: The present invention relates to methods for encapsulating a bioactive agent such as a microorganism, methods for making a modified food, feed, cosmetic, plant health, seed health or pharmaceutical product comprising heteropolymer particles encapsulating a bioactive agent such as a microorganism, compositions and modified products comprising heteropolymer particles of a phenolic compound and a protein, and a bioactive agent encapsulated therein obtainable by such methods. Also provided is a method for delivering a bioactive agent to a subject, comprising administering to said subject the modified food, feed, cosmetic, plant health, seed health or pharmaceutical product described herein.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 28, 2022
    Applicant: Chr. Hansen A/S
    Inventors: Surender Kumar DHAYAL, Martin LUND, Henrik BISGAARD-FRANTZEN, Johannes Maarten VAN DEN BRINK
  • Publication number: 20220211062
    Abstract: The present invention relates to methods for producing dairy food products modified with respect to their firmness and/or gelation time comprising cross-linked protein compounds and to methods for modifying said properties of said dairy food products, as well as to said modified dairy food products obtainable or obtained by such methods. Modification is achieved by in situ generation of H2O2 via carbohydrate oxidase, preferably cellobiose oxidase (EC 1.1.99.18), and cross-linking protein-tyrosine residues in a reaction using H202 via peroxidase (EC 1.11.1.7). Adding small phenolic compounds such as preferably p-coumaric acid or vanillin allows better control of the cross-linking reaction.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 7, 2022
    Applicant: Chr. Hansen A/S
    Inventors: Surender Kumar DHAYAL, Martin LUND, Henrik BISGAARD-FRANTZEN, Johannes Maarten VAN DEN BRINK
  • Publication number: 20220154162
    Abstract: Variants of chymosin with improved milk-clotting properties are disclosed.
    Type: Application
    Filed: January 7, 2022
    Publication date: May 19, 2022
    Applicant: Chr. Hansen A/S
    Inventors: Johannes Maarten VAN DEN BRINK, Jesper Langholm JENSEN, Jonas JACOBSEN, Martin LUND, Iben JEPPESEN, Christian JAECKEL
  • Patent number: 11246320
    Abstract: A method for making a new food, feed or pharmaceutical product comprising addition of a composition comprising cross-linked, via intermolecular covalent isopeptide bonds, casein glycomacropeptide (CGMP) oligomers (CGMP oligomers) to the product.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: February 15, 2022
    Assignee: CHR. HANSEN A/S
    Inventors: Surender Kumar Dhayal, Martin Lund, Johannes Maarten Van Den Brink
  • Patent number: 11234446
    Abstract: A liquid or dried granulated milk clotting aspartic protease enzyme composition and process for isolating a milk clotting aspartic protease enzyme of interest.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: February 1, 2022
    Assignee: CHR. HANSEN A/S
    Inventors: Martin Lund, Jonas Jacobsen, Johannes Maarten Van Den Brink
  • Publication number: 20210380961
    Abstract: Variants of chymosin with improved milk clotting properties.
    Type: Application
    Filed: March 22, 2021
    Publication date: December 9, 2021
    Applicant: CHR. HANSEN A/S
    Inventors: Christian JAECKEL, Martin LUND, Johannes Maarten VAN DEN BRINK
  • Publication number: 20210355471
    Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting betagalactosidase enzyme activity as well as improved methods for reducing the lactose content in compositions, such as dairy products.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 18, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Hans RAJ, Pernille SMITH, Thomas ECKHARDT, Vojislav VOJINOVIC, Charlotte Elisabeth Grüner SCHÖLLER, Johannes Maarten VAN DEN BRINK
  • Patent number: 11174473
    Abstract: Variants of chymosin with improved properties.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: November 16, 2021
    Assignee: CHR. HANSEN A/S
    Inventors: Christian Jaeckel, Martin Lund, Enikö Fodor Hansen, Lone Riisberg, Iben Jeppesen, Johannes Maarten Van Den Brink
  • Publication number: 20210348147
    Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting betagalactosidase enzyme activity wherein the peptide has a pH optimum at acidic conditions.
    Type: Application
    Filed: October 17, 2019
    Publication date: November 11, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Hans RAJ, Johannes Maarten VAN DEN BRINK, Christian GILLELADEN
  • Publication number: 20210230571
    Abstract: Variants of chymosin with improved milk-clotting properties are disclosed.
    Type: Application
    Filed: April 15, 2021
    Publication date: July 29, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Johannes Maarten VAN DEN BRINK, Jesper Langholm JENSEN, Jonas JACOBSEN, Martin LUND, Iben JEPPESEN, Christian JAECKEL
  • Publication number: 20210186042
    Abstract: A process for the reduction of Maillard reaction (and thereby browning) in a cheese food product, wherein the process comprises contacting the product with a hexose oxidase (EC1.1.3.5) and/or cellobiose oxidase (EC 1.1.99.18) enzyme.
    Type: Application
    Filed: May 23, 2019
    Publication date: June 24, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Martin LUND, Camilla Lund NIKOLAJSEN, Johannes Maarten VAN DEN BRINK
  • Patent number: 10982204
    Abstract: Variants of chymosin with improved milk-clotting properties.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: April 20, 2021
    Assignee: CHR. HANSEN A/S
    Inventors: Johannes Maarten Van Den Brink, Jesper Langholm Jensen, Jonas Jacobsen, Martin Lund, Iben Jeppesen, Christian Jaeckel
  • Patent number: 10961524
    Abstract: Variants of chymosin with improved milk clotting properties.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: March 30, 2021
    Assignee: CHR. HANSEN A/S
    Inventors: Christian Jaeckel, Martin Lund, Johannes Maarten Van Den Brink
  • Patent number: 10954505
    Abstract: Variants of chymosin with improved milk clotting properties.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: March 23, 2021
    Assignee: CHR. HANSEN A/S
    Inventors: Christian Jaeckel, Martin Lund, Johannes Maarten Van Den Brink
  • Patent number: 10941389
    Abstract: Variants of chymosin with improved ? S1-casein cleavage and C/P properties.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: March 9, 2021
    Assignee: CHR. HANSEN A/S
    Inventors: Christian Jaeckel, Martin Lund, Enikö Fodor Hansen, Lone Riisberg, Iben Jeppesen, Johannes Maarten Van Den Brink
  • Publication number: 20210045401
    Abstract: A liquid or dried granulated milk clotting aspartic protease enzyme composition and process for isolating a milk clotting aspartic protease enzyme of interest.
    Type: Application
    Filed: September 17, 2020
    Publication date: February 18, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Martin Lund, Jonas Jacobsen, Johannes Maarten Van Den Brink
  • Publication number: 20210032615
    Abstract: The present invention relates to new improved peptides and dimeric peptides exhibiting beta-galactosidase enzyme activity as well as methods using them for reducing the lactose content of milk-based compositions.
    Type: Application
    Filed: August 20, 2020
    Publication date: February 4, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Hans RAJ, Pernille SMITH, Thomas ECKHARDT, Vojislav VOJINOVIC, Charlotte Elisabeth Grüner SCHÖLLER, Johannes Maarten VAN DEN BRINK